Originally published by our sister publication Gastroenterology & Endoscopy News
Professor of Medicine
Chair of the Digestive Disease & Surgery Institute
Cleveland Clinic, Cleveland
Chair of the Digestive Disease & Surgery Institute
Cleveland Clinic, Cleveland
Although infliximab is one of the oldest therapies for IBD, first approved by the FDA for the treatment of Crohn’s disease in 1998, it remains among the most effective treatments available. But because patients in the United States may only receive infliximab intravenously, some patients